对比的转录基因分析揭示了高脂肪饮食引起的小岛功能障碍的潜在分子机制
Shengrong Wan1,2,3, Ying An2,3,4, Wei Fan5
1Experimental Medicine Center, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, China.
Bioscience reports
|June 9, 2023
概括
高脂肪饮食通过改变基因表达来诱导肥胖和小岛功能障碍. 这项研究绘制了胰腺小岛的关键分子变化,揭示了肥胖相关糖尿病背后的机制.
科学领域:
- 代谢研究的研究.
- 分子生物学分子生物学
- 内分泌学 在内分泌学.
背景情况:
- 肥胖与高脂血症,血糖代谢异常和岛屿β细胞损伤有关.
- 导致肥胖诱导的小岛变质的确切机制尚不清楚.
研究的目的:
- 研究高脂肪饮食 (HFD) 诱导的小岛功能障碍背后的分子机制.
- 为了确定差异表达基因 (DEGs) 和受HFD影响的胰腺小岛的途径.
主要方法:
- 给C57BL/6小鼠2个月和6个月的HFD食,以模拟肥胖.
- 用RNA测序来分析孤立小岛的基因表达变化.
- 对DEG进行了基因本体学 (GO) 和KEGG通路分析.
主要成果:
- HFD诱导了基因表达的显著变化,在2个月后262个DEG和6个月后428个.
- 上调的DEGs在内分泌网膜应激和胰腺分泌通路中得到了丰富.
- 下调的DEG与神经元细胞体和蛋白质消化/吸收有关.
- 关键的小岛细胞标记物 (β,α,δ,PP) 的表达减少,而小岛细胞标记物增加.
- 原蛋白基因表达显著下调.
结论:
- HFD显著改变胰腺小岛的基因表达特征,导致功能障碍.
- 细胞内膜网膜应激和改变的分泌途径与HFD诱导的岛屿损伤有关.
- 这项研究提供了对HFD诱导的小岛功能障碍的综合基因表达图,有助于进一步研究与肥胖相关的糖尿病机制.
相关概念视频
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin and C-peptide are co-secreted in...
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.


